Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 2/20 | 0.32 |
| ▸ | S100A4 | P26447 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5009172 | 0.92 | SLC6A2 (0.39) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2485514 | 0.76 | ALDH1A1 (0.31) | — | |
| SCHEMBL5006909 | 0.73 | S100A4 (0.35) | S100A4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3644683 | 0.73 | SLC22A2 (0.39) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL4999960 | 0.72 | SLC22A2 (0.31) | — | |
| Hydrochloric Acid SCHEMBL5003364 | 0.70 | PGR (0.33) | PGRS100A4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5003677 | 0.69 | SLC6A2 (0.41) | PGRSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL5129021 | 0.69 | CYP1A2 (0.39) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL13995259 | 0.68 | PGR (0.41) | PGRS100A4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL2146997 | 0.68 | PGR (0.53) | PGRS100A4SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7446216-B2 | Halogen substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2008-11-04 | — | — | US | disclosed |
| US-20060183874-A1 | Halogen substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060183874-A1 | Halogen substituted metallocene compounds for olefin polymerization | B2M, CDYL, MLX | PGR 1659/4885S100A4 921/4885SLC6A2 4466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.